| Literature DB >> 31679860 |
June Young Chun1, Wan Beom Park1, Nam Joong Kim1, Eun Hwa Choi2, Sebastian Funk3, Myoung-Don Oh4.
Abstract
Measles has been reemerging in South Korea since December 2018 resulting in 185 cases by September 2019. We calculated contact-adjusted immunity levels against measles in South Korea using national seroprevalence data in 2014, vaccination uptake rates, and an age-specific contact matrix. We further explored options to achieve a contact-adjusted immunity level of 93% for herd immunity. The assessed contact-adjusted immunity level has increased from 86% in 2014 to 92% in 2018. Herd immunity could be achieved with immunizing 50% of susceptibles among birth cohorts 1999-2003 in 2018. Contact-adjusted immunity levels against measles have increased recently in South Korea, although they might not yet be high enough to guarantee herd immunity.Entities:
Keywords: Herd immunity; Measles; Republic of Korea; Seroprevalence
Year: 2019 PMID: 31679860 PMCID: PMC6964151 DOI: 10.1016/j.vaccine.2019.10.040
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641
Proportion of the population who is immune to measles by different age groups with original seroprevalence data (2014) and elapsed time adjusted data (2018), and their contact-adjusted immunity levels in South Korea.
| Age group (years) | Proportion of Immune | |
|---|---|---|
| Original (2014) | Shifted (2018) | |
| 0–2 | 0.63 | 0.62 |
| 3–5 | 0.99 | 0.93 |
| 6–11 | 0.98 | 1.00 |
| 12–14 | 0.86 | 0.98 |
| 15–19 | 0.79 | 0.87 |
| 20–29 | 0.93 | 0.85 |
| 30–39 | 0.96 | 0.96 |
| 40–49 | 0.97 | 0.96 |
| ≥50 | 1.00 | 1.00 |
Information based on publicly available national data conducted by Korea Centers for Disease Control in 2014 [12].
Plain immunity was calculated by overall proportion of the population immune.
Contact-adjusted immunity was calculated as in [18].
Fig. 1Serial age distribution of measles in South Korea before (A) and after (B) the 2000–2001 outbreak. * denotes that the number includes suspected number of measles cases, not only confirmed cases, since the outbreak is still ongoing.
Fig. 2Scenario modelling for contact-adjusted immunity through raising immunity of each age group by 50% in perspective of 2014 (A) and 2018 (B). The most dramatic effect was achieved in the 15–19 year olds group both in 2014 (C) and 2018 (D), compared to estimated population immunity of 2014 (86%) and 2018 (92%).